| Financial Year |
March 31 2023 |
| Monetary Funds |
864,419,706.18 |
| Held-for-trading Financial Assets |
581,451,440.94 |
| Notes Receivable |
355,542,271.87 |
| Accounts Receivable |
2,432,029,394.87 |
| Advances to Suppliers |
12,556,243.17 |
| Other Receivables |
32,998,071.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,473,015,842.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
210,812,467.48 |
| Total Current Assets |
7,452,504,872.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,829,462.21 |
| Investment Properties |
5,473,489.26 |
| Fixed Assetes |
9,030,321,853.88 |
| Under-construction Projects |
1,692,234,082.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
553,268,176.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
135,837,589.85 |
| Deferred Income Tax Assets |
231,394,240.86 |
| Other Non-Current Assets |
498,567,452.13 |
| Sub-Total of Non-Current Assets |
12,246,299,475.96 |
| Total Assets |
19,698,804,348.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,173,484,368.88 |
| Accounts Payable |
1,702,604,964.49 |
| Accounts Received In Advance |
436,482.30 |
| Employee Compensation Payable |
255,907,080.42 |
| Taxes Payable |
36,562,899.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,293,717,461.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
777,563,336.24 |
| Other Current Liabilities |
22,159,551.18 |
| Sub-Total of Current Liabilities |
5,349,540,900.83 |
| Long-term Loans |
1,260,997,826.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
228,747,261.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,852,284,016.91 |
| Total Liabilities |
7,201,824,917.74 |
| Paid-In Capital(Or Share Stock) |
512,877,535.00 |
| Capital Surplus |
6,189,540,375.16 |
| Surplus Reserve |
256,438,767.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,499,691,855.97 |
| Minority Stockholder's Interest |
3,020,386.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,493,959,044.20 |
| Owner's Equity（Stockholder's Equity） |
12,496,979,430.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,698,804,348.01 |
